2013-11-04T11:31:09-06:00 2012-12-31 861065772 DELOITTE TAX LLP 201 E KENNEDY BLVD STE 1200 TAMPA FL 33602 990 2012-01-01 592602318 MCH RESEARCH INSTITUTE INC MIAM 3056666511 3100 SW 62ND AVENUE MIAMI FL 33155 TIMOTHY BIRKENSTOCK 3056666511 2013-11-04 0 STEVEN E ROVNER P00648526 8132738355 2012 2016-02-25 16:41:14Z TIMOTHY BIRKENSTOCK 3100 SW 62ND AVENUE MIAMI FL 331553009 2371214 0 X WWW.MCH.COM X 1984 FL IMPROVE CHILD HEALTH BY PROVIDING ACCESS TO NEW INNOVATIONS FOR THEDIAGNOSIS, TREATMENT AND CURE OF PEDIATRIC DISEASES PROMOTING RESEARCHTO ADVANCE SCIENCE AND GENERATE KNOWLEDGE IN CHILD HEALTH AND MEDICINE 16 14 34 2 641609 -354155 1809635 1539798 978821 793275 0 0 38159 38141 2826615 2371214 0 0 0 0 2458165 2111459 0 0 0 2026359 1274029 4484524 3385488 -1657909 -1014274 427860 65855 7292363 7258039 -6864503 -7192184 X MIAMI CHILDREN'S HOSPITAL RESEARCH INSTITUTE STUDIES THE ROLE OF NUTRITION IN THE CAUSE, CURE, AND PREVENTION OF CHILDHOOD DISEASES. IN ADDITION TO NUTRITION, RESEARCH CENTERS OF EXCELLENCE ARE ORGANIZED TO FOCUS ON PEDIATRIC CRITICAL CARE, PRIMARY CARE, CELLULAR AND MOLECULAR PATHOBIOLOGY, MOLECULAR GENETICS, AND NEUROSCIENCE. THE COMMON THREAD RUNNING THROUGH ALL THESE RESEARCH AREAS OF EXCELLENCE IS CHRONIC DISEASE, WELLNESS, AND ACUTE CARE. ALL THESE RESEARCH AREAS ARE SUPPORTED BY A CORE LABORATORY. 0 0 3092366 793275 COSTS INCURRED FOR FACILITIES TO CONDUCT SCIENTIFIC RESEARCH BY MEANS OF EXPERIMENTS TO PROMOTE HUMAN KNOWLEDGE IN THE FIELD OF MEDICAL SCIENCE. SEE STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS. 3092366 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 0 1 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 0 0 34 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 X 16 14 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 X FISCAL SERVICES - CONTROLLER 3056666511 3100 SW 62ND AVENUE MIAMI FL 331553009 JEFRY BIEHLER MD 0.10 39.90 X 0 364426 18384 ANSELMO CEPERO MD 0.10 39.90 X 0 0 0 THOMAS M CORNISH 0.10 1.90 X 0 0 0 JARET DAVIS ESQUIRE 0.10 1.90 X 0 0 0 MARIA FRANCO MD 0.10 1.90 X 0 0 0 MICHAEL FUX 0.10 1.90 X 0 0 0 GHISLAIN GOURAIGE JR 0.10 1.90 X 0 0 0 GARY GREGORY 0.10 2.00 X 0 0 0 JUAN C MAS 0.10 2.00 X 0 0 0 JAY MASSIRMAN 0.10 1.90 X 0 0 0 STEVEN MCKEAN 0.10 1.90 X 0 0 0 MARIO MURGADO 0.10 1.90 X 0 0 0 PHILIP NEWCOMM MD 0.10 1.90 X 0 0 0 ALEX SOTO 0.10 1.90 X 0 0 0 KEITH WARD 0.10 1.90 X 0 0 0 NARENDRA KINI MD 0.10 40.00 X X 0 833013 17986 TIMOTHY BIRKENSTOCK 0.10 40.00 X 0 195924 5650 PEDRO ALFARO 0.10 39.90 X 0 679876 15185 JOSE PERDOMO 40.00 X 117439 59211 19403 BYRON BERNAL 40.00 X 149301 0 18321 266740 2132450 94929 2 0 1 0 WESTERN INSTITUTIONAL REVIEW PO BOX 12029 OLYMPIA WA 985082029 RESEARCH PROTOCOL REVIEW 207958 HURON CONSULTING SERVICES LLC 4795 PAYSPHERE CIRCLE CHICAGO IL 60674 CONSULTING SERVICES 171322 2 1479430 60368 1539798 CLINICAL TRIAL REVENUE 900099 641609 641609 GRANT REVENUE 900099 151666 151666 793275 38141 0 38141 38141 38141 2371214 151666 641609 38141 X 266740 266740 1449171 1449171 395548 395548 52764 26382 26382 593890 593890 52 52 42867 42867 27322 27322 362004 362004 37004 37004 SUPPLIES 87900 87900 GRANT RELATED EXPENSE 23771 23771 DUES & SUBSCRIPTIONS 17921 17921 OVERHEAD ALLOCATION 16092 16092 12442 12442 3385488 3092366 293122 0 3928101 3862246 427860 65855 427860 65855 7292363 7258039 7292363 7258039 X -8064379 -8591789 1199876 1399605 -6864503 -7192184 427860 65855 X -1014274 686593 X 0 1 X 1 1 1 X X 0 0 0 SEE PART IV 590638499 3 0 3385488 1 3385488 SCHEDULE A, PART IV, SUPPLEMENTAL INFORMATION: PART I, LINE 11(H), COLUMN (I) NAME OF SUPPORTED ORGANIZATION: VARIETY CHILDREN'S HOSPITAL D/B/A MIAMI CHILDREN'S HOSPITAL RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 3928101 3862246 65855 65855 DUE TO AFFILIATES 7258039 7258039 X DESCRIPTION OF UNCERTAIN TAX POSITIONS UNDER FIN 48: PART X, LINE 2: PART X, LINE 2: THE HOSPITAL BELIEVES THERE IS NO UNCERTAIN TAX LIABILITY WHICH SHOULD BE RECORDED AS OF DECEMBER 31, 2012. 1 1 0 0 0 0 0 0 0 JEFRY BIEHLER MD 0 349385 0 15041 0 0 0 0 0 18384 0 382810 0 0 NARENDRA KINI MD 0 675575 0 157438 0 0 0 0 0 17986 0 850999 0 0 TIMOTHY BIRKENSTOCK 0 195924 0 0 0 0 0 0 0 5650 0 201574 0 0 PEDRO ALFARO 0 275760 0 317090 0 87026 0 0 0 15185 0 695061 0 0 JOSE PERDOMO 107891 59211 9548 0 0 0 0 0 19403 0 136842 59211 0 0 BYRON BERNAL 144795 0 4506 0 0 0 0 0 18321 0 167622 0 0 0 PART I, LINE 3 PART I, LINE 3: THE ORGANIZATION RELIED ON THE METHODS OF ESTABLISHING COMPENSATION FOR THE ORGANIZATION'S CEO/EXECUTIVE DIRECTOR EMPLOYED BY VARIETY CHILDREN'S HOSPITAL D/B/A MIAMI CHILDREN'S HOSPITAL (EIN: 59-0638499). MIAMI CHILDREN'S HOSPITAL USES THE FOLLOWING METHODS TO ESTABLISH SUCH COMPENSATION: - COMPENSATION COMMITTEE - INDEPENDENT COMPENSATION CONSULTANT - WRITTEN EMPLOYMENT CONTRACT - COMPENSATION SURVEY OR STUDY - APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE SUPPLEMENTAL INFORMATION PART III PART I, LINE 4(A) PEDRO ALFARO, TREASURER OF MCH RESEARCH INSTITUTE, INC., RECEIVED A SEVERANCE PAYMENT OF $87,026 DURING THE TAXABLE YEAR, WHICH WAS PAID BY A RELATED ORGANIZATION. SUPPLEMENTAL INFORMATION PART III PART I, LINE 4(B) THE EXECUTIVES PARTICIPATE IN A SUPPLEMENTAL 457(F) DEFINED CONTRIBUTION RETIREMENT ACCOUNT. THE VALUES ARE REPORTED IN SCHEDULE J, PART II, COLUMN C FORM 990, PART VI, SECTION B, LINE 11 THE FOLLOWING DESCRIBES MIAMI CHILDREN'S HOSPITAL RESEARCH INSTITUTE'S PROCESS FOR PROVIDING IT'S BOARD OF DIRECTORS WITH A COPY OF THE FORM 990 AND REVIEWING IT: 1. THE DRAFT TAX FORM 990 WILL BE MAILED TO FINANCE COMMITTEE OF MCH BOARD OF DIRECTORS FOR REVIEW AND COMMENT PRIOR TO REGULARLY SCHEDULED MEETING. 2. THE DRAFT TAX FORM 990 WILL BE REVIEWED WITH THE FINANCE COMMITTEE. 3. QUESTIONS WILL BE ANSWERED AND IF NECESSARY, TAX FORMS WILL BE ADJUSTED. 4. THE FINAL FORM 990 WILL BE POSTED ON THE MCH BOARD OF DIRECTOR'S WEB PORTAL. FORM 990, PART VI, SECTION B, LINE 12C ALL MIAMI CHILDREN'S HOSPITAL RESEARCH INSTITUTE EMPLOYEES ARE INFORMED UPON HIRE, AND ON AN ANNUAL BASIS THEREAFTER, THAT THEY HAVE AN AFFIRMATIVE DUTY TO DISCLOSE ANY ACTUAL, POTENTIAL OR PERCEIVED CONFLICT OF INTEREST. THEY ARE REQUIRED TO COMPLETE A CONFLICT OF INTEREST DISCLOSURE FORM UPON HIRE, ANNUALLY AND WHENEVER A CHANGE IN CIRCUMSTANCES WARRANTS. CONFLICT OF INTEREST DISCLOSURE FORMS ARE FORWARDED TO THE COMPLIANCE DEPARTMENT BY THE TALENT MANAGEMENT AND EFFECTIVENESS DEPARTMENT. THESE FORMS ARE INITIALLY REVIEWED BY COMPLIANCE DEPARTMENT STAFF. WHEN DEEMED NECESSARY, THE COMPLIANCE DEPARTMENT COLLABORATES WITH THE LEGAL DEPARTMENT. CONFLICTS OF INTEREST THAT NECESSITATE BOARD AWARENESS AND ACTION ARE PRESENTED TO THE AUDIT AND COMPLIANCE COMMITTEE OF THE BOARD FOR RESOLUTION AND IMPOSITION OF SANCTIONS, IF WARRANTED. IN ADDITION, ON AN ANNUAL BASIS, BOARD MEMBERS, PRINCIPAL OFFICERS AND BOARD-DELEGATED COMMITTEE MEMBERS SIGN A STATEMENT WHICH AFFIRMS THAT EACH INDIVIDUAL: (A) HAS RECEIVED A COPY OF THE CONFLICT OF INTEREST POLICY; (B) HAS READ AND UNDERSTANDS THE POLICY (C) HAS AGREED TO COMPLY WITH THE POLICY, AND (D) UNDERSTANDS THAT THE HOSPITAL IS A CHARITABLE ORGANIZATION AND THAT IN ORDER TO MAINTAIN ITS FEDERAL EXEMPTION IT MUST ENGAGE PRIMARILY IN ACTIVITIES WHICH ACCOMPLISH ONE OR MORE IF IT'S TAX-EXEMPT PURPOSES. A PROCESS IS IN PLACE FOR MANAGING SITUATIONS IN WHICH IT IS DISCOVERED THAT AN INDIVIDUAL WHO IS COVERED BY THE HOSPITAL'S CONFLICT OF INTEREST POLICY FAILED TO PROPERLY DISCLOSE A POTENTIAL CONFLICT OF INTEREST. FORM 990, PART VI, SECTION B, LINE 15 THE ORGANIZATION AND COMPENSATION COMMITTEE OF MIAM CHILDREN'S HOSPITAL RESEARCH INSTITUTE BOARD OF DIRECTORS CONTRACTS WITH AN EXTERNAL CONSULTANT TO OBTAIN MARKET SURVEYS FOR THE CEO AND OTHER EXECUTIVES. THE CONSULTANT ASSISTS THE ORGANIZATION AND COMPENSATION COMMITTEE IN ESTABLISHING A COMPENSATION PROGRAM FOR THE CEO AND OTHER EXECUTIVES. SURVEY RESULTS AND COMPENSATION BEST PRACTICES ARE SHARED WITH THE ORGANIZATION AND COMPENSATION COMMITTEE OF THE BOARD AND USED IN ESTABLISHING EXECUTIVE SALRAY AND BENEFITS PROGRAMS. FORM 990, PART VI, SECTION C, LINE 19 FORM 990, PART VI, SECTION C, LINE 19: DOCUMENTS THAT ARE REQUIRED TO BE OPEN FOR PUBLIC INSPECTION ARE MADE AVAILABLE UPON REQUEST. OTHER FEES FORM 990, PART IX, LINE 11G OUTSIDE SERVICES: PROGRAM SERVICE EXPENSES 482,716. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 482,716. CASUAL LABOR: PROGRAM SERVICE EXPENSES 8,104. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 8,104. PHYSICIAN FEES: PROGRAM SERVICE EXPENSES 103,070. MANAGEMENT AND GENERAL EXPENSES 0. FUNDRAISING EXPENSES 0. TOTAL EXPENSES 103,070. CHANGES IN NET ASSETS OR FUND BALANCES: FORM 990, PART XI, LINE 9: PRIOR YEAR CONTRIBUTIONS RELEASED FROM RESTRICTIONS 315,073. GRANT REVENUE USED FOR PURCHASE OF PP&E -151,666. NET REALIZED GAIN ON TEMPORARILY RESTRICTED ASSETS 351,396. RECLASS TO RELATED ORGANIZATION 173,025. AMOUNTS REPORTED SEPARATELY -1,235. PROGRAM SERVICE ACCOMPLISHMENTS FORM 990, PART III, LINE 4A MIAMI CHILDREN'S RESEARCH INSTITUTE IS ONE OF THE LARGEST PROVIDERS OF PEDIATRIC MEDICAL RESEARCH IN THE SOUTHEASTERN UNITED STATES. IT CURRENTLY PARTICIPATES IN APPROXIMATELY 214 RESEARCH PROTOCOLS INVOLVING NEW MEDICATIONS AND INTERVENTIONS FOR CHILDREN WITH COMPLEX MEDICAL NEEDS. THE MCH RESEARCH INSTITUTE WAS REACCREDITED IN 2012 BY THE ASSOCIATION OF HUMAN RESEARCH PROTECTION PROGRAMS (AHRPP). THE INSTITUTE WAS THE FIRST PEDIATRIC RESEARCH PROGRAM IN THE STATE OF FLORIDA AND ONE OF THE FEW CHILDREN'S HOSPITALS IN THE NATION TO EARN THIS DISTINCTION, ACHIEVING ACCREDITATION FOR THE FIRST TIME IN 2009. AHRPP ACCREDITATION AFFIRMS THE HOSPITAL'S COMMITMENT TO MAINTAINING THE MOST STRINGENT STANDARDS IN PROTECTING THE HEALTH OF RESEARCH PARTICIPANTS AND EDUCATING PARTICIPANTS AND THEIR FAMILIES REGARDING RISKS AND POTENTIAL BENEFITS OF TAKING PART IN RESEARCH ACTIVITIES. THE MISSION OF THE MIAMI CHILDREN'S HOSPITAL RESEARCH INSTITUTE IS TO PROMOTE RESEARCH FOR THE ADVANCEMENT OF SCIENCE AND TO GENERATE KNOWLEDGE IN CHILD HEALTH AND PEDIATRIC MEDICINE. THE MCH RESEARCH INSTITUTE PARTICIPATES IN BOTH CLINICAL RESEARCH, WHICH TESTS NEW DIAGNOSTIC PROCEDURES, PHARMACEUTICALS, MEDICAL DEVICES AND INTERVENTIONAL PROCEDURES; AND TRANSLATIONAL RESEARCH, WHICH FOCUSES ON TRANSLATING LABORATORY DISCOVERIES TO THE PATIENT-CARE ENVIRONMENT. HOSPITAL DEPARTMENTS THAT ARE PARTICULARLY ACTIVE IN FOSTERING RESEARCH INCLUDE ADOLESCENT MEDICINE, RADIOLOGY, CARDIOLOGY, ENDOCRINOLOGY, GASTROENTEROLOGY, GENETICS, HEMATOLOGY-ONCOLOGY, NEUROSCIENCES, NEPHROLOGY, ORTHOPAEDICS, PSYCHIATRY, PULMONOLOGY AND UROLOGY. AS PART OF ITS WORK IN THE FIELD OF HEMATOLOGY-ONCOLOGY RESEARCH, MIAMI CHILDREN'S HOSPITAL MAINTAINS FULL MEMBERSHIP IN CHILDREN'S ONCOLOGY GROUP, A FEDERALLY FUNDED CONSORTIUM OF PEDIATRIC HOSPITALS AND PEDIATRIC DEPARTMENTS CONDUCTING A LARGE ARRAY OF CLINICAL RESEARCH STUDIES OFFERING LATEST ADVANCEMENTS FOR TREATMENT OF CHILDHOOD CANCERS. FUTURE PLANS FOR THE MCH RESEARCH INSTITUTE INCLUDE ESTABLISHING A MOLECULAR RESEARCH CENTER, A UNIQUE PROGRAM THAT COMBINES CLINICAL AND MOLECULAR MEDICINE TO DELIVER CARE DESIGNED EXPRESSLY FOR THE NEEDS OF THE INDIVIDUAL CHILD. 2012 RESEARCH HIGHLIGHTS: (1) ADVANCING CARE TO PROMOTE FEWER SURGERIES FOR CHILDREN WITH BONE CANCER EMERGING TECHNOLOGY WAS ADAPTED TO MEET THE NEEDS OF A CHILD WITH BONE CANCER IN THE MIAMI CHILDREN'S OPERATING ROOM IN 2012. THE NEW STANMORE JTS NONINVASIVE EXTENDIBLE IMPLANT IS USED FOR PATIENTS WHOSE GROWTH PLATES HAVE BEEN IMPACTED AS A RESULT OF SURGERY TO REMOVE CANCEROUS BONE TISSUE. THE NEW IMPLANTABLE TECHNOLOGY ELIMINATES THE NEED FOR FUTURE SURGERIES TO LENGTHEN LIMBS DURING THE CHILD'S GROWTH YEARS, MAKING POSSIBLE PERIODIC NONINVASIVE LEG ADJUSTMENTS INVOLVING AN EXTERNAL MAGNET. DUE TO THE SPECIFIC NEEDS OF THE CHILD, THE STANMORE DEVICE WAS MODIFIED, REQUIRING THE RESEARCH INSTITUTE TO OBTAIN SPECIAL APPROVAL FROM THE FOOD AND DRUG ADMINISTRATION (FDA). (2) EXPLORING THE RELATIONSHIP BETWEEN BODY MASS INDEX AND SURGICAL SITE INFECTIONS CHILDHOOD OBESITY HAS BECOME A NATIONAL EPIDEMIC, CONTRIBUTING TO A BROAD RANGE OF MEDICAL PROBLEMS AND COMPLICATIONS. IN 2012, THE RESEARCH INSTITUTE EVALUATED THE RELATIONSHIP BETWEEN SURGICAL SITE INFECTIONS IN CHILDREN AND THE PATIENT'S BODY MASS INDEX (BMI), AGE AND GENDER FOLLOWING SURGICAL PROCEDURES. THE STUDY WILL ENABLE PHYSICIANS TO EXAMINE THERAPIES TO REDUCE INFECTIONS, BASED ON THE PATIENT'S BMI AND OTHER FACTORS. (3) HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) IN NONMALIGNANT DISEASE THE RESEARCH INSTITUTE CONTINUES TO COLLABORATE WITH ACADEMIC INSTITUTIONS TO SEEK LESS TOXIC PREPARATORY REGIMENS FOR PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR NONMALIGNANT DISEASES SUCH AS THALASSEMIA. TYPICALLY, THESE PATIENTS UNDERGO EXTENSIVE HIGH-LEVEL CHEMOTHERAPY TO SUPPRESS THEIR IMMUNE SYSTEMS PRIOR TO STEM CELL TRANSPLANTATION. THE GOAL IS TO DEFINE PRACTICES THAT MAY LEAD TO STANDARDIZATION OF LOWER CHEMOTHERAPY TOXICITY LEVELS FOR PATIENTS PRIOR TO THE TRANSPLANT PROCEDURE, PROMOTING FEWER SIDE EFFECTS AND GREATER SAFETY. (4) BREAKTHROUGH TREATMENT FOR CANCER THE RESEARCH INSTITUTE TOOK PRIDE IN THE SUCCESSFUL TREATMENT OF A CANCER PATIENT WHO PARTICIPATED IN A PHASE II FOOD AND DRUG ADMINISTRATION STUDY OF THE IMC-A12 AIGF-I RECEPTOR. THIS LABORATORY-MADE ANTIBODY TARGETS A RECEPTOR COMMON IN PEDIATRIC TUMORS, BINDING TO THE RECEPTOR AND BLOCKING SYNTHESIS OF A PROTEIN NEEDED FOR TUMOR GROWTH. WITHOUT THE PROTEIN, TUMOR CELLS BEGIN TO DIE. THE EFFECTIVENESS OF THE TREATMENT IN THE YOUNG PATIENT, WHO HAD BEEN UNRESPONSIVE TO TRADITIONAL METHODS, SUGGESTS GREAT PROMISE FOR THIS THERAPY GOING FORWARD. EMPLOYEES REPORTED ON W-3 PART V, LINE 2A VARIETY CHILDREN'S HOSPITAL D/B/A MIAMI CHILDREN'S HOSPITAL ("MCH") IS THE APPOINTED PAY AGENT FOR ALL OF ITS AFFILIATES. AS SUCH ONLY MCH ISSUES FORM W-3. MCH WORKER'S COMPENSATION TRUST 3100 SW 62ND AVENUE MIAMI FL 33155 597021572 WC CLAIMS FL 4947(A)(1) N/A VCH 0 PROFESSIONAL LIABILITY TRUST 3100 SW 62ND AVENUE MIAMI FL 33155 592551434 LIAB. CLAIMS FL 4947(A)(1) N/A VCH 0 MIAMI CHILDREN'S HOSPITAL FOUNDATION INC 3100 SW 62ND AVENUE MIAMI FL 33155 591720704 FOUNDATION FL 501(C)(3) 7 VCH 0 VARIETY CHILDREN'S HOSPITAL 3100 SW 62ND AVENUE MIAMI FL 33155 590638499 HOSPITAL FL 501(C)(3) 3 MCHS 0 MIAMI CHILDREN'S HEALTH SYSTEM INC 3100 SW 62ND AVENUE MIAMI FL 33155 453481327 HEALTHCARE FL 501(C)(3) 11 TYPE II N/A 0 PEDIATRIC SPECIALTY GROUP INC 3100 SW 62ND AVENUE MIAMI FL 33155 463756071 INACTIVE FL MCHS 0 MIAMI CHILDREN'S HEALTH SYSTEM FOUNDATION INC 3100 SW 62ND AVENUE MIAMI FL 33155 461784918 FOUNDATION FL 501(C)(3) 7 MCHS 0 CANAVAN PARTNERS C/O COHEN PO BOX 812170 BOCA RATON FL 334812170 650974245 MED.INTERL. P FL N/A CHILDREN'S HEALTH SERVICES INC 3100 SW 62ND AVENUE MIAMI FL 331553009 650438667 PHYSICIAN SUP FL N/A C 0 MIAMI CHILDREN'S INSURANCE CO SPC LTD 720 WEST BAY ROADPO BOX 69GT BUCKI GEORGETOWN CJ 980442086 INSURANCE CJ N/A C 0 CHILDREN'S HEALTH VENTURES INC AND SUBSIDIARIES 3100 SW 62ND AVENUE MIAMI FL 331553009 454541147 MERCHANT WHOLESALE FL N/A C 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 MIAMI CHILDREN'S HOSPITAL FOUNDATION INC C 1479430 FMV